Prevention and Management of Recurrent C. difficile Infection: Expert Perspectives for Improved Patient Outcomes

A continuing medical education activity provided by NAMCP and AAMCN

Prevention and Management of Recurrent C. difficile: Managed Care Considerations for Improved Patient Outcomes is a two-part webinar series focusing on the latest developments
in the treatment and prevention of C. Difficile Infection

This is Part 1 of the series focusing on the prevention and management of recurrent C. difficile infection

This activity is an archive from the webinar held June 23, 2020

This activity is valid from August 1, 2020 to August 1, 2022

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from
Merck Sharp & Dohme Corp.

Description:
The epidemiology and incidence of hospital- and community-acquired Clostridium difficile infection (CDI) has changed over the past decade resulting in increased cases of initial and recurrent infection. Up to 25% of patients with an initial episode of CDI experience disease recurrence. Recurrent CDI is particularly challenging to manage.

Upon completion of this activity, participants will be able to:

  • Assess tools to identify patients who may be at increased risk for recurrent C. difficile infection

  • Outline evidence-based approaches for the management of first and second recurrences of C. difficile infection in diverse patient populations

  • Describe the role of available antimicrobial agents and biologics for treatment and prevention of recurrent C. difficile infection

  • Apply evidence-based and expert consensus strategies for closing critical gaps in C. difficile infection care transitions and coordination
     

Faculty: Paul Feuerstadt, MD, FACG, AGAF
Gastroenterology Center of Connecticut
Assistant Clinical Professor of Medicine
Yale University School of Medicine

Disclosure:

Dr. Feuerstadt serves as a consultant for Roche Diagnostics. He serves on an advisory board for Rebiotix/Ferring Pharmaceutical. He serves on the speaker’s bureau for Merck & Co. His presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jeremy Williams has no real or perceived financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by an educational grant from
Merck Sharp & Dohme Corp.

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue